JAMA Oncology
Brief Report
April 25, 2024
GiacomoMontagna,MD, MPH; Mary M.Mrdutt,MD, MS; Susie X.Sun,MD; CallieHlavin,MD, MPH; Emilia J.Diego,MD; Stephanie M.Wong,MD, MPH; Andrea V.Barrio,MD; Astrid Bottyvan den Bruele,MD; NeslihanCabioglu,MD, PhD; VaradanSevilimedu,MBBS, DrPH; Laura H.Rosenberger,MD, MS; E. ShelleyHwang,MD, MPH; AbigailIngham,MBchB; BärbelPapassotiropoulos,MD; Bich DoanNguyen-Sträuli,MD; ChristianKurzeder,MD; Danilo DíazAybar,MD; DeniseVorburger,MD; Dieter MichaelMatlac,MD; EdvinOstapenko,MD; FabianRiedel,MD; FlorianFitzal,MD; FrancescoMeani,MD; FranziskaFick,MD; JacquelineSagasser,MD; JörgHeil,MD, PhD; HasanKaranlık,MD; Konstantin J.Dedes,MD; LaszloRomics,MD, PhD; MaggieBanys-Paluchowski,MD, PhD; MahmutMuslumanoglu,MD; Maria Del Rosario CuevaPerez,MD; Marcelo ChávezDíaz,MD; MartinHeidinger,MD; Mathias K.Fehr,MD; MatteaReinisch,MD; MustafaTukenmez,MD; NadiaMaggi,MD; NicolaRocco,MD, PhD; NinaDitsch,MD, PhD; Oreste DavideGentilini,MD; Regis R.Paulinelli,MD, PhD; Sebastián SoléZarhi,MD; SherkoKuemmel,MD, PhD; SimonaBruzas,MD; Simonadi Lascio,MD; Tamara K.Parissenti,MD; Tanya L.Hoskin,MS; UweGüth,MD; ValentinaOvalle,MD; ChristophTausch,MD; Henry M.Kuerer,MD, PhD; Abigail S.Caudle,MD; Jean-FrancoisBoileau,MD, MSc; Judy C.Boughey,MD; ThorstenKühn,MD, PhD; MonicaMorrow,MD; Walter P.Weber,MD
online first
JAMA Oncol. 2024; 10.1001/jamaoncol.2024.0578
This cohort study examines oncological outcomes after sentinel lymph node biopsy with dual-tracer mapping or targeted axillary dissection.
JAMA Surgery
Original Investigation
July 19, 2023
Walter P.Weber,MD; ZoltanMatrai,MD, PhD; StefanieHayoz,PhD; ChristophTausch,MD; GuidoHenke,MD; FrankZimmermann,MD; GiacomoMontagna,MD, MPH; FlorianFitzal,MD; MichaelGnant,MD; ThomasRuhstaller,MD; SimoneMuenst,MD; AndreasMueller,MD; LoïcLelièvre,MD; JörgHeil,MD; MichaelKnauer,MD, PhD; DanielEgle,MD; ÁkosSávolt,MD; MartinHeidinger,MD; ChristianKurzeder,MD; TAXIS Study Writing Group
open access
has multimedia
JAMA Surg. 2023; 158(10):1013-1021. 10.1001/jamasurg.2023.2840
This cohort study investigates the association between the omission of axillary dissection and systemic therapy in patients with clinically node-positive breast cancer in the postneoadjuvant setting.